Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for Nocturnal Hypokinesia in Parkinson's Disease
NCT03098368Phase 4Unknown
- Sponsor
- Chulalongkorn University
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Rotigotine Group with Placebo Group (2 arms). Primary endpoint: Nocturnal parameters from wearable sensors at 10 hours. Status: unknown.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03098368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098368.